Literature DB >> 23253894

Point prevalence of pressure ulcers in three second-level hospitals in Mexico.

Iris L Galván-Martínez1, Roberto Narro-Llorente, Favio Lezama-de-Luna, Jesus Arredondo-Sandoval, Ma Rosy Fabian-Victoriano, Ximena Garrido-Espindola, Adriana Lozano-Platonoff, Jose Contreras-Ruiz.   

Abstract

Pressure ulcers (PU) are the source of multiple complications and even death. To our knowledge, there is no available data about PU prevalence in Mexico. The objective of this study was to determine the point prevalence of PU in three second-level hospitals in Mexico. Every adult hospitalised patient was included in each hospital. Age, gender, hospitalisation ward, Braden score, and the number, location and stage of the ulcers encountered were recorded, as well as any pressure relief measures. In total, 294 patients were examined (127 were male); of these, 63 were considered to be at risk. The average age was 48·6 years. The overall prevalence of the PU was 17%. The service with the highest prevalence was the ICU. The most frequent stage was II (32%) and they were most commonly found in the sacrum (74%). The average Braden score of the patients with ulcers was 10, and 21·4% of the patients obtained moderate- to high-risk Braden scores. Of them, 60·3% had ulcers and only 46% had any preventive measures. The prevalence of PU in three hospitals in Mexico is 17%. The most common stage is II and the most commonly affected site is the sacrum. Only 46% of patients with PU had at least one pressure release measure.
© 2012 The Authors. International Wound Journal © 2012 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Epidemiology; Mexico; Point prevalence; Pressure ulcer

Mesh:

Year:  2012        PMID: 23253894      PMCID: PMC7951031          DOI: 10.1111/iwj.12013

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  8 in total

1.  Pressure ulcers in America: prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel monograph.

Authors: 
Journal:  Adv Skin Wound Care       Date:  2001 Jul-Aug       Impact factor: 2.347

Review 2.  Pressure ulcers prevalence, cost and risk assessment: consensus development conference statement--The National Pressure Ulcer Advisory Panel.

Authors: 
Journal:  Decubitus       Date:  1989-05

Review 3.  Risk assessment scales for pressure ulcer prevention: a systematic review.

Authors:  Pedro L Pancorbo-Hidalgo; Francisco Pedro Garcia-Fernandez; Isabel Ma Lopez-Medina; Carmen Alvarez-Nieto
Journal:  J Adv Nurs       Date:  2006-04       Impact factor: 3.187

Review 4.  Pressure ulcers.

Authors:  L F Kanj; S V Wilking; T J Phillips
Journal:  J Am Acad Dermatol       Date:  1998-04       Impact factor: 11.527

5.  Pressure ulcer prevalence in Europe: a pilot study.

Authors:  Katrien Vanderwee; Michael Clark; Carol Dealey; Lena Gunningberg; Tom Defloor
Journal:  J Eval Clin Pract       Date:  2007-04       Impact factor: 2.431

Review 6.  Preventing pressure ulcers: a systematic review.

Authors:  Madhuri Reddy; Sudeep S Gill; Paula A Rochon
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

Review 7.  Protocol for the successful treatment of pressure ulcers.

Authors:  Harold Brem; Courtney Lyder
Journal:  Am J Surg       Date:  2004-07       Impact factor: 2.565

8.  Multi-site study of incidence of pressure ulcers and the relationship between risk level, demographic characteristics, diagnoses, and prescription of preventive interventions.

Authors:  N Bergstrom; B Braden; M Kemp; M Champagne; E Ruby
Journal:  J Am Geriatr Soc       Date:  1996-01       Impact factor: 5.562

  8 in total
  1 in total

Review 1.  Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis.

Authors:  Peter A Lazzarini; Sheree E Hurn; Malindu E Fernando; Scott D Jen; Suzanne S Kuys; Maarten C Kamp; Lloyd F Reed
Journal:  BMJ Open       Date:  2015-11-23       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.